Im pleased to share that the first participants have been dosed in two new studies of PF3944, our investigational ultra-long-acting GLP-1 receptor agonist (GLP-1 RA): VESPER-6, our Phase 3 pivotal trial evaluating monthly dosing, and SOLIS-1, a Phase 2b umbrella study evaluating PF3945 alone and in combination with our investigational ultra-long-acting amylin analog, PF3945
The efficacy of tirzepatide weight loss is evident in its ability to significantly reduce body weight in individuals with type 2 diabetes, offering a promising approach to both glycemic control and weight management
Some researchers have experienced significant gastrointestinal side effects because they were unknowingly taking twice their target dose
The dose dial shows milligrams
Are compounded GLP-1 injections the same as brand-name products
Like research showing the value of platelets in cellular regeneration, studies demonstrate that stem cells have the power to initiate cell differentiation and proliferation and, thus, restore or replace cells helping to reduce pain and improve function
